Analyzing RYAN Stock – A Market Inference Overview

Ryan Specialty logged a 3.6% change during today's afternoon session, and is now trading at a price of $55.95 per share. The S&P 500 index moved -0.0%. RYAN's trading volume is 424,627 compared to the stock's average volume of 845,862.

Ryan Specialty trades -3.53% away from its average analyst target price of $58.0 per share. The 7 analysts following the stock have set target prices ranging from $54.0 to $63.0, and on average have given Ryan Specialty a rating of hold.

If you are considering an investment in RYAN, you'll want to know the following:

  • Ryan Specialty's current price is 623.8% above its Graham number of $7.73, which implies that at its current valuation it does not offer a margin of safety

  • Ryan Specialty has moved 32.3% over the last year, and the S&P 500 logged a change of 29.3%

  • Based on its trailing earnings per share of 0.54, Ryan Specialty has a trailing 12 month Price to Earnings (P/E) ratio of 103.6 while the S&P 500 average is 15.97

  • RYAN has a forward P/E ratio of 26.0 based on its forward 12 month price to earnings (EPS) of $2.15 per share

  • The company has a price to earnings growth (PEG) ratio of 1.57 — a number near or below 1 signifying that Ryan Specialty is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 11.98 compared to its sector average of 1.58

  • Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore.

  • Based in Chicago, the company has 4,401 full time employees and a market cap of $14.57 Billion. Ryan Specialty currently returns an annual dividend yield of 0.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS